The Tolerability and Safety of Low Dose Primaquine for Transmission Blocking in Symptomatic Falciparum Infected Cambodians
Phase of Trial: Phase IV
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Primaquine
- Indications Malaria
- Focus Adverse reactions
- 22 Aug 2016 Status changed from recruiting to completed.
- 31 Mar 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 14 May 2015 New trial record